- Novartis continues "bolt-on" strategy with $1.1B gene therapy buyout – FirstWord Pharma
… neuroscience. Robert Baloh, global head of neuroscience research at the Swiss drugmaker, noted that the deal "reflects our commitment to … - Study reveals how cell types shape human brain networks – Medical Xpress
By pinpointing these cellular foundations, the study, published in Nature Neuroscience, offers a deeper understanding of the cellular foundations of … - Addressing unmet needs for inherited neuromuscular diseases – Novartis
Acquisition of Kate Therapeutics enhances and strengthens Novartis strategic priorities in gene therapy and neuroscience innovation … - Form 4 ProMIS Neurosciences For: Nov 18 Filed by: Milbury Max A. – StreetInsider
Form 4 ProMIS Neurosciences For: Nov 18 Filed by: Milbury Max A. November 20, 2024 7:04 PM. FORM 4, UNITED STATES SECURITIES AND EXCHANGE … - Novartis buys Kate Therapeutics in $1.1B deal, eyes more bolt-on M&A – Endpoints News
Novartis is acquiring Kate Therapeutics for $1.1 billion, focusing on gene therapy and neuroscience. CEO Vas Narasimhan and CFO Harry Kirsch …
